Covered recipient · General Payments record
ANDREW WEI CHONG MAK
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2020–2024
$4,480.85
- Reported across 106 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $868.42 | 42 |
| Education | $84.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $84.99 | 1 |
| Astellas Pharma US Inc | $61.04 | 3 |
| Genentech USA, Inc. | $57.85 | 3 |
| Blueprint Medicines Corporation | $56.61 | 2 |
| Daiichi Sankyo Inc. | $55.67 | 3 |
| PFIZER INC. | $51.40 | 3 |
| Merck Sharp & Dohme Corporation | $50.55 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $50.38 | 2 |
| Alexion Pharmaceuticals, Inc. | $46.40 | 2 |
| Celgene Corporation | $45.11 | 2 |
| Gilead Sciences, Inc. | $42.03 | 2 |
| BeiGene USA, Inc. | $37.74 | 2 |
| ABBVIE INC. | $35.08 | 2 |
| TerSera Therapeutics LLC | $34.02 | 1 |
| ARRAY BIOPHARMA INC | $30.56 | 2 |
| Agios Pharmaceuticals, Inc. | $23.02 | 1 |
| E.R. Squibb & Sons, L.L.C. | $21.73 | 1 |
| Genmab U.S., Inc. | $21.20 | 1 |
| SERVIER PHARMACEUTICALS LLC | $20.90 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.72 | 1 |
| MorphoSys, US Inc. | $19.57 | 1 |
| Lilly USA, LLC | $18.26 | 1 |
| SpringWorks Therapeutics, Inc. | $18.24 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $17.71 | 1 |
| AVEO Pharmaceuticals, Inc. | $16.99 | 1 |
| Acerta Pharma LLC | $15.64 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (43)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.